Fidelity Investments
INBX icon

Fidelity Investments’s Inhibrx INBX Stock Holding History

Fidelity Investments’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Sell
1,134
-51,674
-98% -$5.18M ﹤0.01% 3940
2026
Q1 		$3.55M Buy
52,808
+6,539
+14% +$485K ﹤0.01% 2428
2025
Q4 		$3.66M Buy
46,269
+6,942
+18% +$473K ﹤0.01% 2388
2025
Q3 		$1.32M Buy
39,327
+256
+0.7% +$6.3K ﹤0.01% 2692
2025
Q2 		$558K Buy
39,071
+1,724
+5% +$22.3K ﹤0.01% 2916
2025
Q1 		$522K Sell
37,347
-1,409
-4% -$19.1K ﹤0.01% 2883
2024
Q4 		$597K Buy
38,756
+3,242
+9% +$49.4K ﹤0.01% 2853
2024
Q3 		$556K Buy
35,514
+7,285
+26% +$102K ﹤0.01% 2810
2024
Q2 		$400K Buy
+28,229
New +$441K ﹤0.01% 2809

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's INBX Position: Q2 2026 in Review

Fidelity Investments reduced its Inhibrx (INBX) stake by 98% in Q2 2026, selling an estimated $5.18M and leaving 1,134 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #3940.

Fidelity Investments first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.66M in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Fidelity Investments held 1,134 shares of Inhibrx worth $107K as of Q2 2026.
  • Fidelity Investments sold 51,674 Inhibrx shares in Q2 2026, an estimated $5.18M.
  • Inhibrx made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3940 holding.
  • Fidelity Investments first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • Fidelity Investments's Inhibrx position peaked at $3.66M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.